… Approves New Intravenous Formulation Of Pfizer’s Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension Revatio is Only … who are temporarily unable to take oral medicine, but are otherwise clinically and haemodynamically stable. …
European Commission Approves New Intravenous Formulation Of Pfizer’s Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension Revatio is Only PAH Treatment in Its Class with Approved I.V. Formulation, Allowing

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Random Posts

Related posts:

  1. European Commission Approves New Intravenous Formulation Of Pfizer’s Revatio (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
  2. FDA Approves Intravenous Formulation Of Pfizer’s Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations
  3. European Commission Approves New Intravenous Formulation Of Pfizer’s Revatio (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension